Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for EXELIXIS, INC. · Oncology-focused biotechnology company

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Lobbyists on this filing 1
  • RON KIND Former member of Congress New on this filing
    Previously held: Member of Congress, U.S. House of Representatives (1997-2023)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Health Issues

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program.

Medicare/Medicaid

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (P.L. No. 117-169), including implementation and the small biotech exception. Issues related to the Small Biotech Innovation Act (S. 1930 / H.R. 3731).

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem